L
Liquidia Corp D
D
LQDA
13.190
USD
-0.44
(-3.23%)
مغلق
حجم التداول
66,028
الربح لكل سهم
-1
العائد الربحي
-
P/E
-8
حجم السوق
1,127,540,885
الأخبار المقالات
العنوان: Liquidia Corp
القطاع: Healthcare
الصناعة: Biotechnology
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.